of 2016 with the Non-Performing Loans (NPLs) to total loans ratio at the end of 2Q17 at 5.8%, increasing from 5.6% as of the end of 2016. On Special Asset Management business, the Bank sold non
) Gross Profit 474.83 14.30 602.83 13.87 (127.99) (21.23) 1,014.55 14.49 1,136.61 13.67 (122.06) (10.74) EBITDA 614.59 18.51 771.86 17.76 (157.27) (20.38) 1,372.61 19.60 1,375.58 16.55 (2.97) (0.22) Net
subsidiaries for Year 2017 period ended December 31, 2017 and would like to clarify on the annual operating results as follows: The consolidated net profit attributable to equity owners of the Company for the
medical treatments when compared to income from medical treatments went up 1.94% from CMR a subsidiary went up 3.73% due to expending employment increase and depreciation of building is increasing. The cost
increased 7.31%, it increased in portion of increasing revenue but expenses were at the same level as last year and finance cost decreased 14.18% from last year from liability decreased too. The Company had
31, 2019 as follows: The Company reported net profit for the first quarter 2019 of Baht 0.98 million, comparing with the same period last year which had net loss of Baht 41.94 million, increasing by
follows: 1. To approve payment of interim dividend for the operating results of January to June 2017 from net profit and retained earnings under the Company's financial statement, to the shareholders, at an
August 2018 as follows: 1. To approve payment of interim dividend for the operating results of January to June 2017 from net profit and retained earnings under the Company's financial statement, to the
August 2018 as follows: 1. To approve payment of interim dividend for the operating results of January to June 2018 from net profit and retained earnings under the Company's financial statement, to the